Lettland - lettiska - Zāļu valsts aģentūra

medice arzneimittel putter gmbh & co.kg, germany - metilfenidāta hidrohlorīds - ilgstošās darbības kapsula, cietā - 20 mg

Lettland - lettiska - Zāļu valsts aģentūra

medice arzneimittel putter gmbh & co.kg, germany - metilfenidāta hidrohlorīds - ilgstošās darbības kapsula, cietā - 30 mg

Europeiska unionen - lettiska - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - multiple mieloma - antineoplastiski līdzekļi - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Europeiska unionen - lettiska - EMA (European Medicines Agency)

stada arzneimittel ag - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiski līdzekļi - oyavas in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. oyavas in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. papildinformāciju par cilvēka epidermas augšanas faktora 2 receptora (her2) statusu, lūdzu, skatiet 5. sadaļā. oyavas in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with oyavas in combination with capecitabine. sīkāku informāciju par her2 statusu, lūdzu, skatiet 5. sadaļā. oyavas, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. oyavas, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5. oyavas in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. oyavas, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. oyavas, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents. oyavas, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents (see section 5. oyavas, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Europeiska unionen - lettiska - EMA (European Medicines Agency)

zoetis belgium sa  - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - imunoloģiskie līdzekļi - kaķi - aktīvās imunizācijas veselīgu kaķi deviņas nedēļas, vai vecāki pret kaķu panleukopenia un kaķu leikēmija vīrusi un pret elpošanas ceļu slimībām, ko izraisa kaķu saslimšanu vīrusu, kaķu calicivirus un chlamydophila felis.

Lettland - lettiska - Pārtikas un veterinārais dienests, Zemkopības ministrija

nutra manufacturing, inc. - kapsula

Europeiska unionen - lettiska - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - kuņģa-zarnu trakta stromas audzēji - citi antineoplastiskie līdzekļi pārstāvji, proteīnkināzes inhibitori - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Europeiska unionen - lettiska - EMA (European Medicines Agency)

bayer animal health gmbh - imidakloprīdu, moksidektīns - antiparazītu līdzekļi, insekticīdi un repelentu līdzekļi - dogs; cats; ferrets - dogsfor suņiem, kas cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (ctenocephalides felis),attieksme pret nokošana utis (trichodectes canis),ārstēšana, ausu ērces invāzijas (otodectes cynotis), sarcoptic kašķis (ko izraisa sarcoptes scabiei var. canis), demodicosis (ko izraisa demodex canis),profilakses heartworm slimības (l3 un l4 kāpuru par dirofilaria immitis),ārstēšanas cirkulācijas microfilariae (dirofilaria immitis),ārstēšanu, ādas dirofilariosis (pieaugušo posmos dirofilaria repens)lai novērstu ādas dirofilariosis (l3 kāpuriem par dirofilaria repens),samazinot apritē microfilariae (dirofilaria repens),novēršanu angiostrongylosis (l4 kāpuru un mazuļu vidū angiostrongylus vasorum),attieksme pret angiostrongylus vasorum un crenosoma vulpis,profilakse spirocercosis (spirocerca lupi),attieksme pret eucoleus (syn. capillaria) boehmi (pieaugušajiem),attieksme pret aci tārps thelazia callipaeda (pieaugušajiem),infekciju ārstēšanai ar kuņģa-zarnu trakta nematodes (l4 kāpuru, mazuļu pieaugušajiem un pieaugušajiem par toxocara canis, ancylostoma caninum un uncinaria stenocephala, pieaugušajiem, toxascaris leonina un trichuris vulpis). produktu var izmantot kā daļu no blusu alerģiskā dermatīta (fad) terapijas stratēģijas.. catsfor kaķiem, kas cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (ctenocephalides felis),ārstēšana, ausu ērces invāzijas (otodectes cynotis),attieksme pret notoedric kašķis (notoedres cat),apstrādes lungworm eucoleus aerophilus (syn. capillaria aerophila) (pieaugušie),novēršanu lungworm slimības (l3/l4 kūniņas aelurostrongylus abstrusus),apstrādes lungworm aelurostrongylus abstrusus (pieaugušajiem),attieksme pret aci tārps thelazia callipaeda (pieaugušajiem),profilakses heartworm slimības (l3 un l4 kāpuru par dirofilaria immitis),infekciju ārstēšanai ar kuņģa-zarnu trakta nematodes (l4 kāpuru, mazuļu pieaugušajiem un pieaugušajiem par toxocara cat un ancylostoma tubaeforme). produktu var izmantot kā daļu no blusu alerģiskā dermatīta (fad) terapijas stratēģijas.. ferretsfor mājas seski cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (ctenocephalides felis),profilakses heartworm slimības (l3 un l4 kāpuru par dirofilaria immitis).

Europeiska unionen - lettiska - EMA (European Medicines Agency)

dechra veterinary products a/s - meloxicam - pretiekaisuma un pretreimatisma līdzekļi - dogs; cats - mutvārdu apturēšana:suņiem pret iekaisumu un sāpes, gan akūtu, gan hronisku balsta un kustību aparāta slimības. Šķīdums injekcijām:suņiem pret iekaisumu un sāpes, gan akūtu, gan hronisku balsta un kustību aparāta slimības. pēcoperācijas sāpju un iekaisuma samazināšana pēc ortopēdisko un mīksto audu operācijas. kaķiem:samazināt pēcoperācijas sāpes pēc ovariohysterectomy un neliels mīksto audu ķirurģija.

Europeiska unionen - lettiska - EMA (European Medicines Agency)

virbac s.a. - deslorelīna acetāts - hipofīzes un hipotalāma hormoni un analogi - dogs; ferrets - lai radītu īslaicīgu neauglību veseliem, veseliem, seksuāli nobriedušiem vīriešu dzimuma suņiem un seskiem.